Funding
The trial was funded by the National Key R&D Program of China during the 13th Five-year Plan Period (Grant No. 2016YFC1300700), the National Key Clinical Specialty Construction Project, and the Project of the Shanghai Science and Technology Commission (Grant No. 17441907000) while being sponsored by unrestricted grants from the MicroPort Company.